Phase I study of temsirolimus, capecitabine appears safe; positive survival trend seen
Thursday, May 17, 2012 - 16:30
in Health & Medicine
A Phase I clinical trial examining the safety of combining temsirolimus and capecitabine in advanced malignancies suggests the two agents can be given safely to patients. In addition researchers conducting the study in cancer patients whose tumors have resisted multiple treatments say the combination demonstrates "promising evidence" of disease control and should be studied in a Phase II trial.